News & Events

News & Events

Latest

Blue and red shaded image depicting cancer cells at a microscopic level
Blue and red shaded image depicting cancer cells at a microscopic level
Using AI to build a cellular time machine
University of Washington researcher Kevin Lin is working to reconstruct the hidden history of a cell, from healthy to diseased, using a single tissue snapshot. With a $2 million award from the National Institute of General Medical Sciences (NIGMS), he aims to develop a suite of AI-driven tools that can build a “computational time machine” for human biology that will help researchers identify therapeutic targets at the earliest stages of disease, long before patients experience symptoms.
Health Sciences building aerial
Health Sciences building aerial
UW Biostatistics maintains top ranking
The University of Washington Department of Biostatistics continues to rank among the top ten graduate programs in the United States, according to the U.S.News & World Report’s 2026 Best Graduate Schools released late Monday.
Willow Crawford-Crudell
Willow Crawford-Crudell
Student profile: Willow Crawford-Crudell
Q&A with PhD student Willow Crawford-Crudell discussing what inspired her to pursue biostatistics, experience in the UW PhD program, and goals for the future.
University of Washington aeriel view looking down on cherry trees in Quad
University of Washington aeriel view looking down on cherry trees in Quad
2026 capstone projects explore trends in clinical care and understanding cellular function
In 2026, student teams from the UW Biostatistics MS Capstone program collaborated with UW research centers to evaluate trends in treatments for patients with breast cancer and appendicitis. A third project explored whether cell shape is related to cellular function, and whether this relationship can be detected computationally.
Photo FDA sign outside FDA building
Photo FDA sign outside FDA building
Are Bayesian Statistics Coming to a Clinical Trial Near You?
MEDPAGE TODAY,

The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. UW Professor of Biostatistics Thomas Fleming weighs in with his thoughts.